Literature DB >> 22980944

[Evidence-based anti-platelet treatment: PAPPS recommendations].

Carlos Brotons Cuixart1, José María Lobos Bejarano, Enrique Martín Rioboó, Antonio Maiques Galán.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22980944      PMCID： PMC7025623          DOI： 10.1016/j.aprim.2012.07.004

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  7 in total

1.  Duration of dual antiplatelet therapy after implantation of drug-eluting stents.

Authors:  Seung-Jung Park; Duk-Woo Park; Young-Hak Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Ki-Hoon Han; Seong-Wook Park; Sung-Cheol Yun; Sang-Gon Lee; Seung-Woon Rha; In-Whan Seong; Myung-Ho Jeong; Seung-Ho Hur; Nae-Hee Lee; Junghan Yoon; Joo-Young Yang; Bong-Ki Lee; Young-Jin Choi; Wook-Sung Chung; Do-Sun Lim; Sang-Sig Cheong; Kee-Sik Kim; Jei Keon Chae; Deuk-Young Nah; Doo-Soo Jeon; Ki Bae Seung; Jae-Sik Jang; Hun Sik Park; Keun Lee
Journal:  N Engl J Med       Date:  2010-03-15       Impact factor: 91.245

2.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

3.  Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

Authors:  F Gerald R Fowkes; Jacqueline F Price; Marlene C W Stewart; Isabella Butcher; Gillian C Leng; Alistair C H Pell; Peter A G Sandercock; Keith A A Fox; Gordon D O Lowe; Gordon D Murray
Journal:  JAMA       Date:  2010-03-03       Impact factor: 56.272

4.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Authors:  Deepak L Bhatt; Keith A A Fox; Werner Hacke; Peter B Berger; Henry R Black; William E Boden; Patrice Cacoub; Eric A Cohen; Mark A Creager; J Donald Easton; Marcus D Flather; Steven M Haffner; Christian W Hamm; Graeme J Hankey; S Claiborne Johnston; Koon-Hou Mak; Jean-Louis Mas; Gilles Montalescot; Thomas A Pearson; P Gabriel Steg; Steven R Steinhubl; Michael A Weber; Danielle M Brennan; Liz Fabry-Ribaudo; Joan Booth; Eric J Topol
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

Review 5.  Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.

Authors:  Sreenivasa Rao Kondapally Seshasai; Shanelle Wijesuriya; Rupa Sivakumaran; Sarah Nethercott; Sebhat Erqou; Naveed Sattar; Kausik K Ray
Journal:  Arch Intern Med       Date:  2012-01-09

6.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

Review 7.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Authors:  Giorgia De Berardis; Michele Sacco; Giovanni F M Strippoli; Fabio Pellegrini; Giusi Graziano; Gianni Tognoni; Antonio Nicolucci
Journal:  BMJ       Date:  2009-11-06
  7 in total
  2 in total

1.  The effectiveness of a health promotion with group intervention by clinical trial. Study protocol.

Authors:  Maria-Antonia Campo Osaba; José-Luis Del Val; Carolina Lapena; Vicencia Laguna; Araceli García; Olga Lozano; Ziortza Martín; Rómulo Rodriguez; Enriqueta Borrás; Francesc Orfila; María Teresa Tierno
Journal:  BMC Public Health       Date:  2012-03-19       Impact factor: 3.295

2.  Variability in screening prevention activities in primary care in Spain: a multilevel analysis.

Authors:  Magdalena Rosell-Murphy; Teresa Rodriguez-Blanco; Julio Morán; Mariona Pons-Vigués; Josep M Elorza-Ricart; Jordi Rodríguez; Clara Pareja; María Ángeles Nuin; Bonaventura Bolíbar
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.